Auxilium Pharmaceuticals Inc., a Malvern specialty biopharmaceuticals company, appointed Peter Brandt to its board. Brandt was president and CEO of Noven Pharmaceuticals, a specialty pharmaceutical company, until late 2009, when the company was acquired by Hisamitsu.
Ansaris, a drug discovery company that is a division of Locus Pharmaceuticals, a privately held biopharmaceutical company, elected Christopher M. Cashman to its board. Cashman was the CEO of Protez Pharmaceuticals, acquired by Novartis in 2008.
Associated Builders and Contractors, New Jersey Chapter, a trade organization, elected Brian P. Wiest treasurer. He is a senior accountant at Wouch, Maloney & Co. L.L.P., Horsham.
Carolyn Short was elected to the board of directors of the Pennsylvania Innocence Project, a nonprofit project housed at Temple University's Beasley School of Law that works to exonerate people convicted wrongly of crimes. Smart is a partner at Reed Smith and is a former Philadelphia assistant district attorney.